Clinicien(ne) chercheur(e)

Dr Gilles O’Hara

Cardiologie

gilles.ohara@criucpq.ulaval.ca

Publications

Trier par année :

Champagne J, Poirier P, Dumesnil JG, Desaulniers D, Boudreault JR, O'Hara G, Gilbert M, Philippon F. Permanent pacemaker lead entrapment: role of the transesophageal echocardiography. Pacing Clin Electrophysiol 2002; 25(7):1131-4.
Champagne J, Poirier P, O'Hara G, Gilbert M, Soucy B, Philippon F. Differential effect of right and left carotid sinus massage: implications for sudden rate drop pacing algorithm.. Can J Cardiol 2002; 18(7):763-7.
Déry JP, Gilbert M, O'Hara G, Champagne J, Desaulniers D, Cartier P, Philippon F. Pacemaker contact sensitivity: case report and review of the literature.. Pacing Clin Electrophysiol 2002; 25(5):863-5.
Eap CB, Lessard E, Baumann P, Brawand-Amey M, Yessine MA, O'Hara G, Turgeon J. Role of CYP2D6 in the stereoselective disposition of venlafaxine in humans.. Pharmacogenetics 2003; 13(1):39-47.
O'Hara GE, Charbonneau L, Chandler M, Vidaillet HJ, Philippon F, Sami M, Rocco TA, Padder FA, Champagne J, Pratt CM, Coutu B, Wyse DG. Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rh. Am J Cardiol 2005; 96(6):815-21.
Plante I, Fournier D, Ricard G, Drolet B, O'Hara G, Champagne J, Mathieu P, Baillot R, Daleau P. Electrophysiological characterization of three non-synonymous single nucleotide polymorphisms (R87Q, A251T, and P307S) found in hKv1.5.. Pflugers Arch 2006; 452(3):316-23.
Rait MH, Volgman AS, Charbonneau L, Pudder FA, O'Hara G, Kerr D. Prediction of the recurrence of atrial fibrillation after cardioversion in the AFFIRM study.. Am Heart J 2006; 151(2):390-6.
Champagne J, Echahidi N, Philippon F, St-Pierre A, Molin F, Blier L, Gilbert M, Villeneuve J, Mohty D, O'Hara G. Usefulness of transesophageal echocardiography in the isolation of pulmonary veins in the treatment of atrial fibrillation.. Pacing Clin Electrophysiol 2007; 30(0):S116-9.
Echahidi N, Pibarot P, O'Hara G, Mathieu P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery.. J Am Coll Cardiol 2008; 51(8):793-801.
Echahidi N, Philippon F, O'Hara G, Champagne J. Life-Threatening Left Atrial Wall Hematoma Secondary to a Pulmonary Vein Laceration: An Unusual Complication of Catheter Ablation for Atrial Fibrillation.. J Cardiovasc Electrophysiol 2008; 19(5):556-8.
Echahidi N, Mohty D, Pibarot P, Després JP, O'Hara G, Champagne J, Philippon F, Daleau P, Voisine P, Mathieu P. Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery.. Circulation 2007; 116(11):I213-9.
Michaud V, Vanier MC, Brouillette D, Roy D, Verret L, Noel N, Taillon I, O'Hara G, Gossard D, Champagne M, Goodman K, Renaud Y, Brown A, Phillips M, Ajami AM, Turgeon J. Combination of Phenotype Assessments and CYP2C9-VKORC1 Polymorphisms in the Determination of Warfarin Dose Requirements in Heavily Medicated Patients.. Clin Pharmacol Ther 2007; 0(0):.
Schoels W, Steinhaus D, Johnson WB, O'Hara G, Schwab JO, Jenniskens I, Degroot PJ, Tang F, Helmling E. Optimizing implantable cardioverter-defibrillator treatment of rapid ventricular tachycardia: antitachycardia pacing therapy during charging.. Heart Rhythm 2007; 4(7):879-85.
Küpper B, Yee R, O'Hara G, Simpson CS, Della Bella P, Workel M, Hull M, Heuer H. Do small (6.6 Fr.) active and passive fixation defibrillation leads perform as well as larger sized leads? A multi-centre analysis.. Europace 2007; 9(8):657-61.
Michaud V, Vanier MC, Brouillette D, Roy D, Verret L, Noel N, Taillon I, O'Hara G, Gossard D, Champagne M, Goodman K, Renaud Y, Brown A, Phillips M, Ajami AM, Turgeon J. Combination of phenotype assessments and CYP2C9-VKORC1 polymorphisms in the determination of warfarin dose requirements in heavily medicated patients.. Clin Pharmacol Ther 2008; 83(5):740-8.
Girerd N, Pibarot P, Fournier D, Daleau P, Voisine P, O'Hara G, Després JP, Mathieu P. Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery.. Eur Heart J 2009; 30(10):1270-8.
Magne J, Dubois M, Champagne J, Dumesnil JG, Pibarot P, Philippon F, O'Hara G, Sénéchal M.. Usefulness of NT-pro BNP monitoring to identify echocardiographic responders following cardiac resynchronization therapy.. Cardiovasc Ultrasound 2009; 7(1):39.
Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O'Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG,. Rhythm control versus rate control for atrial fibrillation and heart failure.. N Engl J Med 2008; 358(25):2667-77.
Sénéchal M, Lancelloti P, Garceau P, Champagne J, Dubois M, Magne J, Blier L, Molin F, Philippon F, Dumesnil JG, Pierard L, O'Hara G. Usefulness and limitation of dobutamine stress echocardiography to predict acute response to cardiac resynchronization therapy.. Echocardiography 2010; 27(1):50-7.
Sénéchal M, Lancellotti P, Magne J, Garceau P, Champagne J, Blier L, Molin F, Philippon F, Marie M, O'Hara G, Dubois M. Contractile Reserve Assessed Using Dobutamine Echocardiography Predicts Left Ventricular Reverse Remodeling after Cardiac Resynchronization Therapy: Prospective Validation in Patients with Left Ventricular Dyssynchrony.. Echocardiography 2010; 27(6):668-76.
Sénéchal M, Lancellotti P, Magne J, Garceau P, Champagne J, Philippon F, O'Hara G, Moonen M, Dubois M. Impact of mitral regurgitation and myocardial viability on left ventricular reverse remodeling after cardiac resynchronization therapy in patients with ischemic cardiomyopathy.. Am J Cardiol 2010; 106(1):31-7.
Fromentin S, Sarrazin JF, Champagne J, Nault I, Philippon F, Molin F, Blier L, O'Hara G. Prospective comparison between conventional transseptal puncture and transseptal needle puncture with radiofrequency energy.. J Interv Card Electrophysiol 2011; 31(3):237-42.
O'Hara GE, Philippon F, Gilbert M, Champagne J, Michaud V, Charbonneau L, Pruneau G, Hamelin BA, Geelen P, Turgeon J. Combined Administration of Quinidine and Propafenone for Atrial Fibrillation: The CAQ-PAF Study.. J Clin Pharmacol 2011; 0(0):Epub.
Girerd N, Pibarot P, Daleau P, Voisine P, O'Hara G, Després JP, Mathieu P. Statins Reduce Short- and Long-Term Mortality Associated With Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: Impact of Postoperative Atrial Fibrillation and Statin Therapy on Survival.. Clin Cardiol 2012; 35(7):430-6.
Mardigyan V, Verma A, Birnie D, Guerra P, Redfearn D, Becker G, Champagne J, Sapp J, Gula L, Parkash R, Macle L, Crystal E, O'Hara G, Khaykin Y, Sturmer M, Veenhuyzen GD, Greiss I, Sarrazin JF, Mangat I, Novak P, Skanes A, Roux JF, Chauhan V, Hadjis T, Morillo CA, Essebag V. Anticoagulation management pre- and post atrial fibrillation ablation: a survey of canadian centres.. Can J Cardiol 2013; 29(2):219-23.
Steinberg C, Philippon F, O'Hara G, Molin F. Selective Left Ventricular Sensing Lead Implantation to Overcome Undersensing of Ventricular Fibrillation During Implantable Cardioverter Defibrillator Implantation.. Can J Cardiol 2013; 29(6):751.e3-6.
Steinberg C, Sarrazin JF, Philippon F, Bouchard MA, O'Hara G, Molin F, Nault I, Blier L, Champagne J. Detection of high incidence of Riata lead breaches by systematic postero-anterior and lateral chest X-ray in a large cohort.. Europace 2013; 15(3):402-8.
Healey JS, Hohnloser SH, Glikson M, Neuzner J, Viñolas X, Mabo P, Kautzner J, O'Hara G, Van Erven L, Gadler F, Appl U, Connolly SJ. The rationale and design of the Shockless IMPLant Evaluation (SIMPLE) trial: a randomized, controlled trial of defibrillation testing at the time of defibrillator implantation.. Am Heart J 2012; 164(2):146-52.
Sarrazin JF, Philippon F, Tessier M, Guimond J, Molin F, Champagne J, Nault I, Blier L, Nadeau M, Charbonneau L, Trottier M, O'Hara G. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections.. J Am Coll Cardiol 2012; 59(18):1616-25.
Leather RA, Gardner M, Green MS, Kavanagh K, Macle L, Ahmad K, Gray C, Ayala-Paredes F, Guerra PG, O'Hara G, Essebag V, Sturmer M, Baranchuk A, Hruczkowski T, Lahevsky I, Novak P, Chakrabarti S, Harris L, Gula LJ, Morillo C, Sanatani S, Hamilton RM, Gow RM, Krahn AD.. Charting a course for cardiac electrophysiology training in Canada: the vital role of fellows in advanced cardiovascular care.. Can J Cardiol 2013; 29(11):1527-30.
Steinberg C, Sarrazin JF, Philippon F, Champagne J, Molin F, Nault I, Blier L, Bouchard MA, Arsenault J, O'Hara G.. PA/Lateral Chest X-Ray is Equivalent to Cine-Fluoroscopy for the Detection of Conductor Externalization in Defibrillation Leads.. Pacing Clin Electrophysiol 2015; 38(1):77-83.
Healey JS, Hohnloser SH, Glikson M, Neuzner J, Mabo P, Vinolas X, Kautzner J, O'Hara G, VanErven L, Gadler F, Pogue J, Appl U, Gilkerson J, Pochet T, Stein KM, Merkely B, Chrolavicius S, Meeks B, Foldesi C, Thibault B, Connolly SJ. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).. Lancet 2015; 385(9970):785-91.
O'Hara G. Working on the front line.. Clin Med 2015; 15(4):358-61.
Nadeau PL, Champagne J, Molin F, Sarrazin JF, O'Hara G, Nault I, Blier L, Charbonneau É, Jacques F, Philippon F. Extra-anatomic Course of a Right Ventricular Pacing Lead: Clinical Implications.. Can J Cardiol 2015; 0(0):Epub.
Rodriguez-Gabella T, Nombela-Franco L, Regueiro A, Jiménez-Quevedo P, Champagne J, O'Hara G, Bernier M, Macaya C, Rodés-Cabau J. Single Antiplatelet Therapy Following Left Atrial Appendage Closure in Patients With Contraindication to Anticoagulation.. J Am Coll Cardiol 2016; 68(17):1920-1921.
Masiero S, Connolly SJ, Birnie D, Neuzner J, Hohnloser SH, Vinolas X, Kautzner J, O'Hara G, VanErven L, Gadler F, Wang J, Mabo P, Glikson M, Kutyifa V, Wright DJ, Essebag V, Healey JS. Wound haematoma following defibrillator implantation: incidence and predictors in the Shockless Implant Evaluation (SIMPLE) trial.. Europace 2016; 0(0):Epub.
Amit G, Wang J, Connolly SJ, Glikson M, Hohnloser S, Wright DJ, Brachmann J, Defaye P, Neuzner J, Mabo P, Vanerven L, Vinolas X, O'Hara G, Kautzner J, Appl U, Gadler F, Stein K, Konstantino Y, Healey JS. Apical versus Non-Apical Lead: Is ICD Lead Position Important for Successful Defibrillation?. J Cardiovasc Electrophysiol 2016; 27(5):581-6.
Rodés-Cabau J, O'Hara G, Paradis JM, Bernier M, Rodriguez-Gabella T, Regueiro A, O'Connor K, Beaudoin J, Puri R, Côté M, Champagne J. Changes in Coagulation and Platelet Activation Markers Following Transcatheter Left Atrial Appendage Closure.. Am J Cardiol 2017; 120(1):87-91.
Michel DC, Passos SR, Simões-Araujo JL, Baraúna AC, da Silva K, Parma MM, Melo IS, De Meyer SE, O'Hara G, Zilli JE. Bradyrhizobium centrolobii and Bradyrhizobium macuxiense sp. nov. isolated from Centrolobium paraense grown in soil of Amazonia, Brazil.. Arch Microbiol 2017; 199(5):657-664.
Masiero S, Connolly SJ, Birnie D, Neuzner J, Hohnloser SH, Vinolas X, Kautzner J, O'Hara G, VanErven L, Gadler F, Wang J, Mabo P, Glikson M, Kutyifa V, Wright DJ, Essebag V, Healey JS. Wound haematoma following defibrillator implantation: incidence and predictors in the Shockless Implant Evaluation (SIMPLE) trial.. Europace 2017; 19(6):1002-1006.
Regueiro A, Bernier M, O'Hara G, O'Connor K, Paradis JM, Beaudoin J, Rodriguez-Gabella T, Champagne J, Rodés-Cabau J.. Left atrial appendage closure: Initial experience with the ultraseal device.. Catheter Cardiovasc Interv 2017; 90(5):817-23.
Regueiro A, Cruz-Gonzalez I, Bethencourt A, Nombela-Franco L, Champagne J, Asmarats L, Jiménez-Quevedo P, Rodriguez-Gabella T, Rama-Merchan JC, Puri R, O'Hara G, Rodés-Cabau J. Long-term outcomes following percutaneous left atrial appendage closure in patients with atrial fibrillation and contraindications to anticoagulation.. J Interv Card Electrophysiol 2018; 52(1):53-9.
Vamos M, Healey JS, Wang J, Connolly SJ, Mabo P, Van Erven L, Kautzner J, Glikson M, Neuzner J, O'Hara G, Vinolas X, Gadler F, Hohnloser SH. Implantable cardioverter-defibrillator therapy in hypertrophic cardiomyopathy: A SIMPLE substudy.. Heart Rhythm 2017; 0(0):Epub.
Gitenay E, Molin F, Blais S, Tremblay V, Gervais P, Plourde B, Jacques F, Steinberg C, Sarrazin JF, Charbonneau É, Parent H, O'Hara GE, Champagne J, Philippon F. Cardiac Implantable Electronic Device Infection: Detailed Analysis of Cost Implications.. Can J Cardiol 2018; 34(8):1026-1032.
Asmarats L, Bernier M, O'Hara G, Paradis JM, O'Connor K, Beaudoin J, Bilodeau S, Cavalcanti R, Champagne J, Rodés-Cabau J. Hemodynamic impact of percutaneous left atrial appendage closure in patients with paroxysmal atrial fibrillation.. J Interv Card Electrophysiol 2018; 53(2):151-157.
Sarrazin JF, Philippon F, Sellier R, André P, O'Hara G, Molin F, Nault I, Blier L, Champagne J. Clinical performance of different DF-4 implantable cardioverter defibrillator leads.. Pacing Clin Electrophysiol 2018; 0(0):Epub.
Nombela-Franco L, Rodés-Cabau J, Cruz-Gonzalez I, Freixa X, Asmarats L, Gutiérrez H, Sahay S, Rodriguez-Gabella T, Moreno-Samos JC, Tirado-Conte G, Goncalves-Ramirez LR, Rama-Merchan JC, Amat-Santos IJ, O'Hara G, Martín-Yuste V, Bethencourt A, Jimenez-Quevedo P, Macaya C. Incidence, Predictors, and Prognostic Value of Acute Kidney Injury Among Patients Undergoing Left Atrial Appendage Closure.. JACC Cardiovasc Interv 2018; 11(11):1074-1083.
Sandhu RK, Quadros KK, Liu YY, Glikson M, Kutyifa V, Mabo P, Hohnloser S, O'Hara G, VanErven L, Neuzner J, Kautzner J, Gadler F, Vinolas X, Appl U, Connolly SJ, Healey JS. Sedation strategies for defibrillation threshold testing: safety outcomes with anaesthesiologist compared to proceduralist-directed sedation: an analysis from the SIMPLE study.. Europace 2018; 20(11):1798-1803.
Vamos M, Healey JS, Wang J, Connolly SJ, Mabo P, Van Erven L, Kautzner J, Glikson M, Neuzner J, O'Hara G, Vinolas X, Gadler F, Hohnloser SH. Implantable cardioverter-defibrillator therapy in hypertrophic cardiomyopathy: A SIMPLE substudy.. Heart Rhythm 2018; 15(3):386-392.
Asmarats L, Masson JB, Pagnotta PA, Cook S, Foresti M, Ibrahim R, Sukiennik A, Sabiniewicz R, Maffeo D, Carballo J, Cruz-González I, Grasso C, Pisano F, Senatore G, Tarantini G, Kasongo A, Chiarito M, Puricel S, Messas N, Moreno-Samos JC, O'Hara G, Rodés-Cabau J.. Percutaneous Left Atrial Appendage Closure With the Ultraseal Device: Insights From the Initial Multicenter Experience.. JACC Cardiovasc Interv 2018; 11(19):1932-1941.
Nault I, André P, Plourde B, Leclerc F, Sarrazin JF, Philippon F, O'Hara G, Molin F, Steinberg C, Roy K, Blier L, Champagne J. Validation of a novel single lead ambulatory ECG monitor - Cardiostat? - Compared to a standard ECG Holter monitoring.. J Electrocardiol 2018; 53(0):57-63.
Steinberg C, Philippon F, Sanchez M, Fortier-Poisson P, O'Hara G, Molin F, Sarrazin JF, Nault I, Blier L, Roy K, Plourde B, Champagne J. A Novel Wearable Device for Continuous Ambulatory ECG Recording: Proof of Concept and Assessment of Signal Quality.. Biosensors (Basel) 2019; 9(1):E17.
Nault I, André P, Plourde B, Leclerc F, Sarrazin JF, Philippon F, O'Hara G, Molin F, Steinberg C, Roy K, Blier L, Champagne J. Validation of a novel single lead ambulatory ECG monitor - Cardiostat? - Compared to a standard ECG Holter monitoring.. J Electrocardiol 2019; 53(0):57-63.
Steinberg C, Philippon F, O'Hara G, Champagne J. Orthodromic atrioventricular reentrant tachycardia using a concealed isoproterenol-sensitive accessory pathway.. Indian Pacing Electrophysiol J 2020; 20(2):73-77.
Freitas-Ferraz AB, Rodés-Cabau J, Junquera Vega L, Beaudoin J, O'Connor K, Turgeon PY, Paradis JM, Ferreira-Neto A, Asmarats L, Champagne J, O'Hara G, Bernier M. Transesophageal echocardiography complications associated with interventional cardiology procedures.. Am Heart J 2020; 221(0):19-28.
Neuzner J, Hohnloser SH, Kutyifa V, Glikson M, Dietze T, Mabo P, Vinolas X, Kautzner J, O'Hara G, Lawo T, Brachmann J, VanErven L, Gadler F, Appl U, Wang J, Connolly SJ, Healey JS. Effectiveness of single- vs dual-coil implantable defibrillator leads: An observational analysis from the SIMPLE study.. J Cardiovasc Electrophysiol 2019; 30(7):1078-1085.
Steinberg C, Dognin N, Sodhi A, Champagne C, Staples JA, Champagne J, Laksman Z, Sarrazin JF, Bennett M, Plourde B, Deyell MW, Andrade JG, Roy K, Yeung-Lai-Wah JA, Hawkins NM, Mondésert B, Blier L, Nault I, O'Hara G, Krahn AD, Philippon F, Chakrabarti S. DREAM-ICD-II study.. Circulation 2022; 145(10):742-753.
Steinberg C, Nadeau-Routhier C, André P, Philippon F, Sarrazin JF, Nault I, O'Hara G, Blier L, Molin F, Plourde B, Roy K, Larose E, Arsenault M, Champagne J. Ventricular Arrhythmia in Septal and Apical Hypertrophic Cardiomyopathy: The French-Canadian Experience.. Front Cardiovasc Med 2020; 7(0):548564.
Asmarats L, O'Hara G, Champagne J, Paradis JM, Bernier M, O'Connor K, Beaudoin J, Junquera L, Del Val D, Muntané-Carol G, Côté M, Rodés-Cabau J. Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure.. Circ Cardiovasc Interv 2020; 13(8):e009039.
Freitas-Ferraz AB, Bernier M, Vaillancourt R, Ugalde Figueroa PA, Nicodème F, Paradis JM, Champagne J, O'Hara G, Junquera L, Del Val D, Muntané-Carol G, O'Connor K, Beaudoin J, Rodés-Cabau J. Safety of Transesophageal Echocardiography to Guide Structural Cardiac Interventions.. J Am Coll Cardiol 2020; 75(25):3164-3173.
De Larochellière H, Champagne J, Sarrazin JF, Steinberg C, Philippon F, Roy K, Molin F, O'Hara G, Plourde B, Blier L, Nault I. Findings of remote monitoring of implantable cardioverter defibrillators during the COVID-19 pandemic.. Pacing Clin Electrophysiol 2020; 43(11):1366-1372.
Steinberg C, Cheung CC, Wan D, Sodhi A, Claros S, Staples JA, Philippon F, Laksman Z, Sarrazin JF, Bennett M, Plourde B, Deyell MW, Andrade JG, Roy K, Yeung-Lai-Wah JA, Molin F, Hawkins NM, Blier L, Nault I, O'Hara G, Krahn AD, Champagne J, Chakrabarti S. Driving Restrictions and Early Arrhythmias in Patients Receiving a Primary-Prevention Implantable Cardioverter-Defibrillator (DREAM-ICD) Study.. Can J Cardiol 2020; 36(8):1269-1277.
Philippon F, O'Hara GE, Champagne J, Hohnloser SH, Glikson M, Neuzner J, Mabo P, Vinolas X, Kautzner J, Gadler F, Lashevsky N, Connolly SJ, Liu YY, Healey JS. Rate, Time Course, and Predictors of Implantable Cardioverter Defibrillator Infections: An Analysis From the SIMPLE Trial.. CJC Open 2020; 2(5):354-359.
Lemery R, Downar E, Roy D, Green M, Abdullah H, Talajic M, O'Hara G. Hein Wellens and Electrical Stimulation of the Heart in the Netherlands. The Canadian Contingent.. Can J Cardiol 2021; 37(2):180-181.
Andrade JG, Wells GA, Deyell MW, Bennett M, Essebag V, Champagne J, Roux JF, Yung D, Skanes A, Khaykin Y, Morillo C, Jolly U, Novak P, Lockwood E, Amit G, Angaran P, Sapp J, Wardell S, Lauck S, Macle L, Verma A; EARLY-AF Investigators (Champagne J, Nault I, Sarrazin JF, Philippon F, O'Hara G, Molin F, Blier L, Plourde B, Roy K, Steinberg C parmi les collaborateurs).. Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation.. N Engl J Med 2021; 384(4):305-315.
Freitas-Ferraz AB, Bernier M, O'Connor K, Beaudoin J, Champagne J, Paradis JM, O'Hara G, Muntané-Carol G, Alperi A, Faroux L, Junquera L, Rodés-Cabau J. Safety and effects of volume loading during transesophageal echocardiography in the pre-procedural work-up for left atrial appendage closure.. Cardiovasc Ultrasound 2021; 19(1):3.
Salaun E, Conde IS, O'Connor K, Beaudoin J, Bernier F, O'Hara G, Champagne J, Paradis JM, Dognin N, Lemyre M, Rodes-Cabau J, Bernier M. Billowing Motion of the Polyester Fabric Cover With WATCHMAN FLX Device: The Wind Sailing Effect.. JACC Cardiovasc Interv 2021; 14(16):e201-e204.
Champagne C, Dognin N, Molin F, Steinberg C, Philippon F, Sarrazin JF, O'Hara G, Nault I, Roy K, Plourde B, Blier L, Champagne J. Twiddler Syndrome without Lead Dislodgment Discovered by Remote Monitoring.. Case Rep Cardiol 2021; 2021(0):8816524.
Faroux L, Cruz-González I, Arzamendi D, Freixa X, Nombela-Franco L, Peral V, Caneiro-Queija B, Mangieri A, Trejo-Velasco B, Asmarats L, Regueiro A, McInerney A, Mas-Lladó C, Estevez-Loureiro R, Laricchia A, O'Hara G, Rodés-Cabau J. Short-term direct oral anticoagulation or dual antiplatelet therapy following left atrial appendage closure in patients with relative contraindications to chronic anticoagulation therapy.. Int J Cardiol 2021; 333(0):77-82.
Faroux L, Cruz-González I, Arzamendi D, Freixa X, Nombela-Franco L, Peral V, Caneiro-Queija B, Mangieri A, Trejo-Velasco B, Asmarats L, Regueiro A, McInerney A, Mas-Lladó C, Estevez-Loureiro R, Laricchia A, O'Hara G, Rodés-Cabau J. Effect of Glomerular Filtration Rates on Outcomes Following Percutaneous Left Atrial Appendage Closure.. Am J Cardiol 2021; 145(0):77-84.
Mesnier J, Cruz-González I, Peral V, Nombela-Franco L, Freixa X, Laffond AE, Mas-Lladó C, McInerney A, Regueiro A, O'Hara G, Rodés-Cabau J. Ten-Year Outcomes Following Percutaneous Left Atrial Appendage Closure in Patients With Atrial Fibrillation and Absolute or Relative Contraindications to Chronic Anticoagulation.. Circ Cardiovasc Interv 2021; 14(8):e010821.
Faroux L, Cruz-González I, Arzamendi D, Freixa X, Nombela-Franco L, Peral V, Caneiro-Queija B, Mangieri A, Trejo-Velasco B, Asmarats L, Regueiro A, McInerney A, Morcuende Gonzalez A, Estevez-Loureiro R, Laricchia A, O'Hara G, Rodés-Cabau J. Incidence, predictors, and clinical impact of bleeding recurrence in patients with prior gastrointestinal bleeding undergoing LAAC.. Pacing Clin Electrophysiol 2021; 44(7):1216-1223.
Sedaghat A, Vij V, Al-Kassou B, Gloekler S, Galea R, Fürholz M, Meier B, Valgimigli M, O'Hara G, Arzamendi D, Agudelo V, Asmarats L, Freixa X, Flores-Umanzor E, De Backer O, Søndergaard L, Nombela-Franco L, McInerney A, Korsholm K, Nielsen-Kudsk JE, Afzal S, Zeus T, Operhalski F, Schmidt B, Montalescot G, Guedeney P, Iriart X, Miton N, Saw J, Gilhofer T, Fauchier L, Veliqi E, Meincke F, Petri N, Nordbeck P, Rycerz S, Ognerubov D, Merkulov E, Cruz-González I, Gonzalez-Ferreiro R, Bhatt DL, Laricchia A, Mangieri A, Omran H, Schrickel JW, Rodes-Cabau J, Nickenig G. Device-Related Thrombus After Left Atrial Appendage Closure: Data on Thrombus Characteristics, Treatment Strategies, and Clinical Outcomes From the EUROC-DRT-Registry.. Circ Cardiovasc Interv 2021; 14(5):e010195.
Dognin N, Salaun E, Champagne C, Domain G, O'Hara G, Philippon F, Paradis JM, Faroux L, Beaudoin J, O'Connor K, Bernier M, Rodés-Cabau J, Champagne J. Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation.. J Interv Card Electrophysiol 2022; 64(2):497-509.
Silva I, Beaudoin J, Champagne J, Paradis JM, Bernier M, O'Connor K, Dognin N, Lemyre M, Rodes-Cabau J, O'Hara G, Salaun E. Post-release shift with Watchman FLX devices during left atrial appendage closure: the "popcorn effect".. EuroIntervention 2022; 18(2):e181-e182.
Philippon F, Domain G, Sarrazin JF, Nault I, O'Hara G, Champagne J, Steinberg C. Evolution of Devices to Prevent Sudden Cardiac Death: Contemporary Clinical Impacts.. Can J Cardiol 2022; 38(4):515-525.
Mesnier J, Cruz-González I, Arzamendi D, Freixa X, Nombela-Franco L, Peral V, Caneiro-Queija B, Mangieri A, Trejo-Velasco B, Asmarats L, Regueiro A, McInerney A, Mas-Lladó C, Estevez-Loureiro R, Laricchia A, O'Hara G, Rodés-Cabau J. Early Discontinuation of Antithrombotic Treatment Following Left Atrial Appendage Closure.. Am J Cardiol 2022; 171(0):91-98.
Domain G, Dognin N, O'Hara G, Rodès-Cabau J, Paradis JM, Strubé C, Bernier M, O'Connor K, Beaudoin J, Philippon F, Salaun E, Champagne J. Experience of Combined Procedure during Percutaneous LAA Closure.. J Clin Med 2022; 11(12):3280.
Salaun E, Bernier M, Paradis JM, Champagne J, Silva Conde I, Beaudoin J, O'Connor K, Dognin N, Alperi A, Mesnier J, Panagides V, Lemyre M, Rodes-Cabau J, O'Hara G. Watchman 2.5^TM versus Watchman FLX^TM device in atypical left atrial anatomies: old fashion never dies.. Acta Cardiol 2023; 78(3):372-376.
Sarrazin JF, Laaouaj J, Philippon F, Sanchez M, Gervais P, Champagne J, Steinberg C, Nault I, Roy K, Plourde B, Blier L, O'Hara G. Safety of Cefazolin Test Dose in Patients With Penicillin Allergy Just Prior to Cardiac Device Implantation: A Single-Centre Experience.. CJC Open 2022; 4(8):695-700.
Georges G, Philippon F, Champagne J, Albert E, O'Hara GE. Leadless Pacemaker Implantation in a Patient With Hypoplasia of the Left Brachiocephalic Vein.. CJC Open 2022; 4(9):810-812.
Mesnier J, Cruz-González I, Arzamendi D, Freixa X, Nombela-Franco L, Peral V, Caneiro-Queija B, Mangieri A, Trejo-Velasco B, Asmarats L, Regueiro A, McInerney A, Mas-Lladó C, Estevez-Loureiro R, Laricchia A, O'Hara G, Rodés-Cabau J. Incidence and Predictors of Early Death in Patients Undergoing Percutaneous Left Atrial Appendage Closure.. JACC Clin Electrophysiol 2022; 8(9):1093-1102.
Vij V, Piayda K, Nelles D, Gloekler S, Galea R, Fürholz M, Meier B, Valgimigli M, O'Hara G, Arzamendi D, Agudelo V, Asmarats L, Freixa X, Flores-Umanzor E, De Backer O, Sondergaard L, Nombela-Franco L, McInerney A, Korsholm K, Nielsen-Kudsk JE, Afzal S, Zeus T, Operhalski F, Schmidt B, Montalescot G, Guedeney P, Iriart X, Miton N, Saw J, Gilhofer T, Fauchier L, Veliqi E, Meincke F, Petri N, Nordbeck P, Ognerubov D, Merkulov E, Cruz-González I, Gonzalez-Ferreiro R, Bhatt DL, Laricchia A, Mangieri A, Omran H, Schrickel JW, Rodes-Cabau J, Sievert H, Nickenig G, Sedaghat A. Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry.. Clin Res Cardiol 2022; 111(11):1276-1285.
Mesnier J, Cepas-Guillén P, Freixa X, Flores-Umanzor E, Hoang Trinh K, O'Hara G, Rodés-Cabau J. Antithrombotic Management After Left Atrial Appendage Closure: Current Evidence and Future Perspectives.. Circ Cardiovasc Interv 2023; 16(5):e012812.
Steinberg C, Gaudreault N, Papadakis AI, Henry C, Champagne J, Philippon F, O'Hara G, Blier L, Plourde B, Nault I, Roy K, Sarrazin JF, Spatz A, Bossé Y. Leucocyte-derived micro-RNAs as candidate biomarkers in Brugada syndrome.. Europace 2023; 25(6):euad145.
Cepas-Guillén P, Flores-Umanzor E, Leduc N, Bajoras V, Perrin N, Farjat-Pasos J, McInerney A, Lafond A, Millán X, Zendjebil S, O'Hara G, Ibrahim R, de Backer O, Cruz-González I, Arzamendi D, Sanchis L, Garot P, Nielsen-Kudsk JE, Nombela-Franco L, Aminian A, Rodés-Cabau J, Freixa X. Impact of Device Implant Depth After Left Atrial Appendage Occlusion.. JACC Cardiovasc Interv 2023; 16(17):2139-2149.
Vij V, Cruz-González I, Galea R, Piayda K, Nelles D, Vogt L, Gloekler S, Fürholz M, Meier B, Räber L, O'Hara G, Arzamendi D, Agudelo V, Asmarats L, Freixa X, Flores-Umanzor E, De Backer O, Sondergaard L, Nombela-Franco L, McInerney A, Salinas P, Korsholm K, Nielsen-Kudsk JE, Afzal S, Zeus T, Operhalski F, Schmidt B, Montalescot G, Guedeney P, Iriart X, Miton N, Saw J, Gilhofer T, Fauchier L, Veliqi E, Meincke F, Petri N, Nordbeck P, Gonzalez-Ferreiro R, Bhatt DL, Laricchia A, Mangieri A, Omran H, Schrickel JW, Rodes-Cabau J, Nickenig G, Sievert H, Sedaghat A. Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT registry.. Clin Res Cardiol 2023; 112(12):1790-1799.
Saw J, Inohara T, Gilhofer T, Uchida N, Pearce C, Dehghani P, Kass M, Ibrahim R, Morillo C, Wardell S, Paradis JM, O'Hara GE. The Canadian WATCHMAN Registry for Percutaneous Left Atrial Appendage Closure.. CJC Open 2023; 5(7):522-529.

Dr Gilles O’Hara

Publications

Soutenir la médecine de demain, maintenant.

Soutenir la médecine
de demain, maintenant.